Allergan Aesthetics, an AbbVie company, launches Faces of Natrelle testimonial program
- AbbVie’s Allergan Aesthetics launched the nationwide Faces of Natrelle testimonial program.
- AbbVie executive Nicole Mowad‑Nassar says the program honors women’s implant stories and counters silence.
- AbbVie links participation to its Allē loyalty program, offering $500 cards for selected augmentation submissions.
Irvine, Calif., Feb. 3, 2026 — Allergan Aesthetics, an AbbVie company, announces the nationwide launch of the Faces of Natrelle® Testimonial Program, inviting eligible breast augmentation and reconstruction patients to share photos, videos and written testimonials. The program asks women who underwent surgery at age 22 or older to submit content for potential feature across Natrelle’s social media, website and other brand channels, positioning real patient stories as an educational resource for those considering aesthetic or reconstructive breast procedures.
Nicole Mowad-Nassar, president of Global Allergan Aesthetics and senior vice president at AbbVie, says the initiative is “about honoring the stories, the decisions, and the transformations of women with breast implants.” The company frames the program as an effort to counter what it describes as outdated perceptions and a lingering culture of silence around breast procedures, and to reflect diverse experiences that can offer clarity and confidence to prospective patients navigating both elective and medically indicated paths.
Selected augmentation participants who are members of AbbVie’s Allē® loyalty program may receive a $500 Allē gift card if their submissions are chosen and approved, with terms, eligibility limits and availability noted by the company; patients who underwent reconstruction are explicitly not eligible for compensation. Natrelle emphasizes that submissions should include a photo or video plus a written account of the patient’s experience with Natrelle Breast Implants, and that featured content will be used to inform and support others contemplating similar procedures.
Patient voices and stigma around breast procedures
Breast augmentation and reconstruction remain among the most popular cosmetic and reconstructive surgeries in the United States, and Allergan frames the Faces of Natrelle program as an attempt to normalize patient narratives and provide peer-driven information. The company highlights the program as part of a broader push to champion women’s voices at each step of the breast aesthetics journey, using firsthand accounts to supplement clinical information and provider consultations.
Marketing strategy and patient engagement for AbbVie
The testimonial initiative aligns with AbbVie’s wider emphasis on patient engagement and direct-to-consumer communication within its aesthetics unit, leveraging social platforms and loyalty programs to build brand trust. By amplifying patient testimonials and linking participation to Allē benefits for some contributors, Allergan seeks to strengthen Natrelle’s presence in a competitive cosmetic device market while positioning patient stories as central to decision-making.
Related Cashu News

CRISPR Therapeutics AG Achieves Financial Progress Amid Advancements in Gene-Editing Portfolio
CRISPR Therapeutics AG (Ticker: UNDEFINED) showcases a pivotal moment in its financial journey with the release of its results for the first quarter of 2026. Highlighting a revenue of $1.46 million, t…

MetaVia to Present Innovative Cardiometabolic Research at 2026 ADA Scientific Sessions
MetaVia is set to showcase its innovative research in cardiometabolic diseases at the upcoming American Diabetes Association (ADA) Scientific Sessions in 2026, following the acceptance of three late-b…

Ionis Pharmaceuticals Advances TRYNGOLZA for Hypertriglyceridemia and Diranersen for Alzheimer's Disease
Ionis Pharmaceuticals has made headlines in the biotechnology sector with the promising potential of its drug TRYNGOLZA, which is designed to treat severe hypertriglyceridemia. During a recent healthc…

ImmunityBio Partners with BCG Laboratory to Enhance Bladder Cancer Treatment Supply and Options
ImmunityBio has secured a critical partnership with Japan's BCG Laboratory to enhance the supply of Bacillus Calmette-Guérin (BCG) in the United States, addressing an urgent need in the treatment of b…